Archives
Eli Lilly's Diabetes Drug Approval Halted by FDA over Facility Quality Issues
The U.S Food Administration declined to approve Eli Lilly's new diabetes drug empagliflozin, citing quality issues at the German factory where the drug will be made, Lilly along with its partner Boehringer Ingelheim said Wednesday.
Latest Research Articles
Exoplanet Imaged in Visible Light Using Basic Digital Camera Technology
Warm River Water Can Break Through Arctic Ice Barriers and Raise Ocean Temperature
Prominence of Female Birdsong Challenges Evolutionary Theory
China's Fossil Treasure Trove Just Got Richer
Sea Level Rise Threatens UNESCO World Heritage Sites
Federal Ruling Grants Critical Habitat to Jaguars in Southwest US
Four Lion Cubs Born at National Zoo in DC [VIDEO]
NASA Image Shows Spiral Galaxy Being Torn
Biologists Use Tracking Devices to Uncover Early Life of Florida's Loggerhead Turtles
Researchers Find 'Disordered Hyperuniformity' in Chicken Eye
High-Protein Diet Linked with Cancer, Early Death
I'll Have What He's Having: Drinking Pals Mimic Alcoholic Drink Orders
MOST POPULAR
-
Is Yerba Mate Nature's Ozempic? Weighing In Risk Vs. Benefits
-
WATCH: 'Ed the Zebra' Airlifted Home After More than a Week on the Run in Tennessee
-
Enjoying Nature: How Outdoor Activities Can Benefit Children & Teens
-
Texas Woman Hopped on a Kayak to Escape Floodwaters With Her Dogs: 'I'm Still in Shock'
-
How Gene Editing Could Save Endangered Species from Extinction
